This study is completed in the United States. It is testing ACT-539313 for Binge-Eating disorders.
Eating disorders, Binge-Eating disordersDrugFrom 18 Years to 55 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Oral ACT-539313 may be useful for adults experiencing eating disorders.
What would participation involve?
Participants may receive Oral ACT-539313, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with eating disorders.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: February 16, 2021
Recruitment status
Completed
Enrollment listed in the registry
136
Sponsor
Idorsia Pharmaceuticals Ltd.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT04753164
Official title
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Proof-of-concept Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT04753164. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 30 sites
Southern California Research
Beverly Hills, California
Site status: Not listed — confirm with the team
Wr-Pri, Llc
Encino, California
Site status: Not listed — confirm with the team
Collaborative Neuroscience Network (CNS)
Garden Grove, California
Site status: Not listed — confirm with the team
Syrentis Clinical Research
Santa Ana, California
Site status: Not listed — confirm with the team
Connecticut Clinical Research - Cromwell
Cromwell, Connecticut
Site status: Not listed — confirm with the team
Clinical Neurosciences Solutions
Jacksonville, Florida
Site status: Not listed — confirm with the team
Behavioral Clinical Research
North Miami, Florida
Site status: Not listed — confirm with the team
Clinical Neuroscience Solutions Inc
Orlando, Florida
Site status: Not listed — confirm with the team
NeuorTrials Research Inc
Atlanta, Georgia
Site status: Not listed — confirm with the team
Psych Atlanta P.C.
Marietta, Georgia
Site status: Not listed — confirm with the team
Capstone Clinical Research
Libertyville, Illinois
Site status: Not listed — confirm with the team
Collective Medical Research
Prairie Village, Kansas
Site status: Not listed — confirm with the team
Harvard Medical School - McLean Hospital
Belmont, Massachusetts
Site status: Not listed — confirm with the team
Boston Clinical Trials, Inc
Boston, Massachusetts
Site status: Not listed — confirm with the team
Precise Research Centers
Flowood, Mississippi
Site status: Not listed — confirm with the team
St. Charles Psychiatric Associates dba Midwest research group
Saint Charles, Missouri
Site status: Not listed — confirm with the team
M3 Wake Research
Las Vegas, Nevada
Site status: Not listed — confirm with the team
ActivMed Practices & Research, Inc.
Portsmouth, New Hampshire
Site status: Not listed — confirm with the team
ActivMed Practices & Research
Portsmouth, New Hampshire
Site status: Not listed — confirm with the team
Bioscience Research
Mount Kisco, New York
Site status: Not listed — confirm with the team
Manhattan Behavioral Medicine PLLC
New York, New York
Site status: Not listed — confirm with the team
The Medical Research Network
New York, New York
Site status: Not listed — confirm with the team
CTI Clinical Research Center
Cincinnati, Ohio
Site status: Not listed — confirm with the team
Patient Priority Clinical Sites
Cincinnati, Ohio
Site status: Not listed — confirm with the team
University of Cincinnati College of Medicine - Lindner Center of HOPE
Mason, Ohio
Site status: Not listed — confirm with the team
North Star Medical Research, LLC
Middleburg Heights, Ohio
Site status: Not listed — confirm with the team
IPS Research Company
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Oregon Center For Clinical Inv.
Portland, Oregon
Site status: Not listed — confirm with the team
Oregon Center for Clinical Investigations, Inc. (OCCI, Inc.)
Salem, Oregon
Site status: Not listed — confirm with the team
Clinical Trials of Texas, Inc. (CTT)
San Antonio, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with eating disorders. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving ACT-539313, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with eating disorders; age range: From 18 Years to 55 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Idorsia Pharmaceuticals Ltd., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
